News & Events
May 6, 2016
FDA Project Grant Natural History Studies for Rare Disease Product Development

Grants Program is to support studies that advance rare disease medical product development

The objective of FDA’s Orphan Products Natural History Grants Program is to support studies that advance rare disease medical product development through characterization of the natural history of rare diseases/conditions, identification of genotypic and phenotypic subpopulations, and development and/or validation of clinical outcome measures, biomarkers and/or companion diagnostics. The ultimate goal of these natural history studies is to support clinical development of products for use in rare diseases or conditions where no current therapy exists or where the proposed product will be superior to the existing therapy.

Deadline: August 15, 2016 for October 14, 2016 application due date.

Read More
Share: